N,N-Diethyl-3-oxobutyramide

We are N,N-Diethyl-3-oxobutyramide CAS:2235-46-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 2235-46-3
Product Name: N,N-Diethyl-3-oxobutyramide
Other Name:
N,N-Diethyl-3-oxobutyramide
N,N-Diethylacetoacetamide
N-Acetoacetyldiethylamine
N,N-diethylacetoacetoamide
N,N-diethyl-acetylacetic amide
1-(N,N-diethylcarbamyl)-2-propanone
N,N-Diethylacetylacetic acid amide
 
Density: 0.994 g/mL at 20 °C(lit.)
Boiling Point: 76 °C(lit.)
Melting Point: -73 °C
Molecular Formula: C8H15NO2
Molecular Weight: 157.21000
Flash Point: 94 °C
Exact Mass: 157.11000
PSA: 37.38000
LogP: 0.83390
Vapour Pressure: 0.0283mmHg at 25°C
Index of Refraction: n20/D 1.471
 
Specification
Appearance: Yellow liquid
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Phosphamidon CAS: 13171-21-6.
Be used as pesticide intermediate, mainly used in the synthesis of α, α-dichloro-N, N-diethylacetoacetamide, which is the intermediate of insecticide Phosphamine.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

N,N-Diethyl-3-oxobutyramide


Related News: The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market.1,2-Etanodiamina, N1- (2-aminoetil) -N2- [3- (dimetoximetilsilil) propil] – CAS:99740-64-4 European companies are the main suppliers of specialty APIs, but due to environmental and cost pressures, APIs have begun to shift to the Asian market.31349-48-1 As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.137156-41-3 As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large.

Related Products
Product Name
2-Chloro-5-trifluoromethylpyridine View Details
Triphenylacetate Cas:595-91-5 View Details
2,4,5-Trifluorotrichloromethyl benzene View Details
2-(4-aminomethylphenyl)benzamide manufacturer HC Blue 12 manufacturer (2R)-2-amino-N-benzyl-3-methoxypropanamide manufacturer 5-Mercapto-1-methyltetrazole manufacturer 1-Butaneboronic acid manufacturer